Market Currents
BrainStorm's (BCLI.OB -2%) NurOwn adult stem cell therapy for treating Lou Gehrig's Disease...
-
Monday, July 23, 2012, 1:55 PM ETBrainStorm's (BCLI.OB -2%) NurOwn adult stem cell therapy for treating Lou Gehrig's Disease brought about "improvement in many of the patients involved" in a small Phase I/II trial. Stem cells derived from patients' own bone marrow were treated with NurOwn before being transplanted back into the patients.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
